1383792-23-1

Basic information

• Product Name: C₂₀H₂₁NO₅
• CAS NO: 1383792-23-1
• Molecular Weight: 355.39
• Mol File: 1383792-23-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₀H₂₁NO₅(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₀H₂₁NO₅(1383792-23-1)
• EPA Substance Registry System: C₂₀H₂₁NO₅(1383792-23-1)

Safety Data

• Hazardous Substances Data: 1383792-23-1(Hazardous Substances Data)

Upstream product

• 33100-06-0 7,8-(methylenedioxy)-2-oxo-1,2,4,5-tetrahydro-3H-3-benzazepine 
• 3893-01-4 2,3-dimethoxybenzyl chloride 
• 1484-85-1 3,4-methylenedioxyphenylethylamine 
• 1160948-77-5 N-[2-cyanomethyl-4,5-(methylenedioxy)phenethyl]trifluoroacetamide 
• 1160948-91-3 N-[2-chloromethyl-4,5-(methylenedioxy)phenethyl]trifluoroacetamide 
• 115665-48-0 N-[3,4-(methylenedioxy)phenethyl]trifluoroacetamide 

Relevant articles and documents

Enantioselective total synthesis of (S)-(+)-lennoxamine through asymmetric hydrogenation mediated by l-proline-tetrazole ruthenium catalyst

A novel asymmetric synthetic strategy to prepare isoindolobenzazepine based lennoxamine alkaloid has been achieved in high ee% starting from 2-(benzo[d][1,3]dioxol-5-yl)ethanamine and 1-(chloromethyl)-2,3-dimethoxybenzene in 5 steps and with a 34% overall yield. The potentiality of this route involved the Bischler-Napieralsky cyclization that leads to tetracyclic indolinium skeleton, generation of chiral center through asymmetric hydrogen-transfer reaction employing l-proline-tetrazole as chiral ligand with Ru/Ir/Rh, and anodic oxidation as the key steps in the synthesis.